Ajanta Pharma Limited Financial Overview
Ajanta Pharma Limited's market cap is currently ₹324.70B. The company's EPS TTM is ₹20.8; its P/E ratio is 33.34; and it has a dividend yield of 1.06%. Ajanta Pharma Limited is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is ₹19.25. See an overview of income statement, balance sheet, and cash flow financials.
